刘晓;洪浩;
LIU Xiao;HONG Hao;Department of Pharmacology,School of Pharmacy,China Pharmaceutical University;

• 1:中国药科大学药学院药理系

摘要(Abstract)：

谷氨酸-谷氨酰胺循环是大脑中谷氨酸合成与代谢的主要途径，谷氨酸作为兴奋性神经递质调节大脑生理功能。近年来，大量研究表明抑郁症的发病过程与谷氨酸-谷氨酰胺循环障碍存在重要联系。基于此，本文综述归纳了谷氨酸生理作用、谷氨酸-谷氨酰胺循环过程、抑郁症中循环障碍表现以及靶向谷氨酸能系统药物在抑郁症中的研究现状，以期为后续研究提供参考依据。
Glutamate-glutamine cycle is the main pathway of glutamate synthesis and metabolism in the brain.Glutamate is one kind of excitatory neurotransmitters for regulating brain physiological function.Recent studies had indicated that the development of depression was associated with dysregulation of glutamate-glutamine cycle.This review focused on physiological characteristics of glutamate, process of glutamate-glutamine cycle, the role of glutamate-glutamine cycle in depression and antidepressants acting on the glutamatergic system, in order to provide reference for future research.

关键词(KeyWords)： 抑郁症;谷氨酸;抗抑郁药
depression;glutamate;antidepressant

Abstract:

Keywords:

基金项目(Foundation): 国家自然科学基金资助项目(81773714)

作者(Authors): 刘晓;洪浩;
LIU Xiao;HONG Hao;Department of Pharmacology,School of Pharmacy,China Pharmaceutical University;

参考文献(References)：

• [1] Malhi G S,Mann J J.Depression [J].Lancet,2018,392(10161):2299-2312.
• [2] Onaolapo A Y,Onaolapo O J.Glutamate and depression:Reflecting a deepening knowledge of the gut and brain effects of a ubiquitous molecule [J].World Journal of Psychiatry,2021,11(7):297-315.
• [3] Abdallah C G,Sanacora G,Duman R S,et al.The neurobiology of depression,ketamine and rapid-acting antidepressants:Is it glutamate inhibition or activation?[J].Pharmacology & Therapeutics,2018,190:148-158.
• [4] Murrough J W,Abdallah C G,Mathew S J.Targeting glutamate signalling in depression:progress and prospects [J].Nature Reviews Drug Discovery,2017,16(7):472-486.
• [5] Eid T,Gruenbaum S E,Dhaher R,et al.The Glutamate-Glutamine Cycle in Epilepsy [J].Advances in Neurobiology,2016,13:351-400.
• [6] Bak L K,Schousboe A,Waagepetersen H S.The glutamate/GABA-glutamine cycle:aspects of transport,neurotransmitter homeostasis and ammonia transfer [J].Journal of Neurochemistry,2006,98(3):641-653.
• [7] Mallick H N.Understanding safety of glutamate in food and brain [J].Indian J Physiol Pharmacol,2007,51(3):216-234.
• [8] Kitamura A,Tsurugizawa T,Uematsu A,et al.New therapeutic strategy for amino acid medicine:effects of dietary glutamate on gut and brain function [J].J Pharmacol Sci,2012,118(2):138-144.
• [9] Rothman S M,Olney J W.Glutamate and the pathophysiology of hypoxic--ischemic brain damage [J].Annals of neurology,1986,19(2):105-111.
• [10] Egerton A,Grace A A,Stone J,et al.Glutamate in schizophrenia:Neurodevelopmental perspectives and drug development [J].Schizophrenia Research,2020,223:59-70.
• [11] Mahmoud S,Gharagozloo M,Simard C,et al.Astrocytes Maintain Glutamate Homeostasis in the CNS by Controlling the Balance between Glutamate Uptake and Release [J].Cells,2019,8(2):184.
• [12] Daikhin Y,Yudkoff M.Compartmentation of brain glutamate metabolism in neurons and glia [J].The Journal of Nutrition,2000,130(4):1026-1031.
• [13] Choudary P V,Molnar M,Evans S J,et al.Altered cortical glutamatergic and GABAergic signal transmission with glial involvement in depression [J].Proceedings of the National Academy of Sciences of the United States of America,2005,102(43):15653-15658.
• [14] Zhang J,Narr K L,Woods R P,et al.Glutamate normalization with ECT treatment response in major depression [J].Mol Psychiatry,2013,18(3):268-270.
• [15] Gigante A D,Bond D J,Lafer B,et al.Brain glutamate levels measured by magnetic resonance spectroscopy in patients with bipolar disorder:a meta-analysis [J].Bipolar Disorders,2012,14(5):478-487.
• [16] Luykx J J,Laban K G,van den Heuvel M P,et al.Region and state specific glutamate downregulation in major depressive disorder:a meta-analysis of (1)H-MRS findings [J].Neuroscience and Biobehavioral Reviews,2012,36(1):198-205.
• [17] Li S X,Han Y,Xu L Z,et al.Uncoupling DAPK1 from NMDA receptor GluN2B subunit exerts rapid antidepressant-like effects [J].Mol Psychiatry,2018,23(3):597-608.
• [18] Fullana M N,Covelo A,Bortolozzi A,et al.In vivo knockdown of astroglial glutamate transporters GLT-1 and GLAST increases excitatory neurotransmission in mouse infralimbic cortex:Relevance for depressive-like phenotypes [J].The Journal of the European College of Neuropsychopharmacology,2019,29(11):1288-1294.
• [19] Wei Y B,Melas P A,Villaescusa J C,et al.MicroRNA 101b Is Downregulated in the Prefrontal Cortex of a Genetic Model of Depression and Targets the Glutamate Transporter SLC1A1 (EAAT3) in Vitro [J].The International Journal of Neuropsychopharmacology,2016,19(12):69.
• [20] Beneyto M,Kristiansen L V,Oni-Orisan A,et al.Abnormal glutamate receptor expression in the medial temporal lobe in schizophrenia and mood disorders [J].Neuropsychopharmacology,2007,32(9):1888-1902.
• [21] Chourbaji S,Vogt M A,Fumagalli F,et al.AMPA receptor subunit 1 (GluR-A) knockout mice model the glutamate hypothesis of depression [J].FASEB Journal,2008,22(9):3129-3134.
• [22] Lerma J,Marques J M.Kainate receptors in health and disease [J].Neuron,2013,80(2):292-311.
• [23] Mao L M,Wang J Q.Alterations in mGlu5 receptor expression and function in the striatum in a rat depression model [J].Journal of Neurochemistry,2018,145(4):287-298.
• [24] Belozertseva I V,Kos T,Popik P,et al.Antidepressant-like effects of mGluR1 and mGluR5 antagonists in the rat forced swim and the mouse tail suspension tests [J].European Neuropsychopharmacology,2007,17(3):172-179.
• [25] Joffe M E,Santiago C I,Oliver K H,et al.mGlu(2) and mGlu(3) Negative Allosteric Modulators Divergently Enhance Thalamocortical Transmission and Exert Rapid Antidepressant-like Effects [J].Neuron,2020,105(1):46-59.
• [26] O'Connor R M,Pusceddu M M,O'Leary O F,et al.Hippocampal group III mGlu receptor mRNA levels are not altered in specific mouse models of stress,depression and antidepressant action [J].Pharmacology,Biochemistry,and Behavior,2013,103(3):561-567.
• [27] Gee C E,Peterlik D,Neuhauser C,et al.Blocking metabotropic glutamate receptor subtype 7 (mGlu7) via the Venus flytrap domain (VFTD) inhibits amygdala plasticity,stress,and anxiety-related behavior [J].The Journal of Biological Chemistry,2014,289(16):10975-10987.
• [28] Berman R M,Cappiello A,Anand A,et al.Antidepressant effects of ketamine in depressed patients [J].Biol Psychiatry,2000,47(4):351-354.
• [29] Murrough J W,Iosifescu D V,Chang L C,et al.Antidepressant efficacy of ketamine in treatment-resistant major depression:a two-site randomized controlled trial [J].The American Journal of Psychiatry,2013,170(10):1134-1142.
• [30] Singh J B,Fedgchin M,Daly E J,et al.A Double-Blind,Randomized,Placebo-Controlled,Dose-Frequency Study of Intravenous Ketamine in Patients With Treatment-Resistant Depression [J].The American Journal of Psychiatry,2016,173(8):816-826.
• [31] Zhang K,Hashimoto K.An update on ketamine and its two enantiomers as rapid-acting antidepressants [J].Expert Review of Neurotherapeutics,2019,19(1):83-92.
• [32] Corriger A,Pickering G.Ketamine and depression:a narrative review [J].Drug Design,Development and Therapy,2019,13:3051-3067.
• [33] Katalinic N,Lai R,Somogyi A,et al.Ketamine as a new treatment for depression:a review of its efficacy and adverse effects [J].The Australian and New Zealand Journal of Psychiatry,2013,47(8):710-727.
• [34] Kryst J,Kawalec P,Pilc A.Efficacy and safety of intranasal esketamine for the treatment of major depressive disorder [J].Expert Opinion on Pharmacotherapy,2020,21(1):9-20.
• [35] Preskorn S H,Baker B,Kolluri S,et al.An innovative design to establish proof of concept of the antidepressant effects of the NR2B subunit selective N-methyl-D-aspartate antagonist,CP-101,606,in patients with treatment-refractory major depressive disorder [J].Journal of Clinical Psychopharmacology,2008,28(6):631-637.
• [36] Stasiuk W,Serefko A,Szopa A,et al.Traxoprodil augments the antidepressant-like activity of agomelatine but not of mianserin or tianeptine in the forced swim test in mice [J].Pharmacological Reports,2016,68(5):960-963.
• [37] Menniti F S,Pagnozzi M J,Butler P,et al.CP-101,606,an NR2B subunit selective NMDA receptor antagonist,inhibits NMDA and injury induced c-fos expression and cortical spreading depression in rodents [J].Neuropharmacology,2000,39(7):1147-1155.
• [38] Poleszak E,Stasiuk W,Szopa A,et al.Traxoprodil,a selective antagonist of the NR2B subunit of the NMDA receptor,potentiates the antidepressant-like effects of certain antidepressant drugs in the forced swim test in mice [J].Metabolic Brain Disease,2016,31(4):803-814.
• [39] Henter I D,de Sousa R T,Zarate C A,et al.Glutamatergic Modulators in Depression [J].Harvard Review of Psychiatry,2018,26(6):307-319.
• [40] Quiroz J A,Tamburri P,Deptula D,et al.Efficacy and Safety of Basimglurant as Adjunctive Therapy for Major Depression:A Randomized Clinical Trial [J].JAMA psychiatry,2016,73(7):675-684.
• [41] Lindemann L,Porter R H,Scharf S H,et al.Pharmacology of basimglurant (RO4917523,RG7090),a unique metabotropic glutamate receptor 5 negative allosteric modulator in clinical development for depression [J].The Journal of Pharmacology and Experimental Therapeutics,2015,353(1):213-233.
• [42] Chaki S.mGlu2/3 receptor as a novel target for rapid acting antidepressants [J].Advances in Pharmacology,2020,89:289-309.
• [43] Freudenberg F,Celikel T,Reif A.The role of α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) receptors in depression:central mediators of pathophysiology and antidepressant activity?[J].Neuroscience and Biobehavioral Reviews,2015,52:193-206.
• [44] Machado-Vieira R,Zarate C A.Proof of concept trials in bipolar disorder and major depressive disorder:a translational perspective in the search for improved treatments [J].Depression and Anxiety,2011,28(4):267-281.
• [45] 曾婕，洪浩.兴奋性谷氨酸转运蛋白2作为抑郁治疗靶点的研究进展 [J].今日药学，2021,31(6):401-404.
• [46] Hashimoto K.Emerging role of glutamate in the pathophysiology of major depressive disorder [J].Brain Research Reviews,2009,61(2):105-123.
• [47] Amin S N,Hassan S S,Khashaba A S,et al.Hippocampal and Cerebellar Changes in Acute Restraint Stress and the Impact of Pretreatment with Ceftriaxone [J].Brain Sciences,2020,10(4):193.
• [48] Kang S,Li J,Bekker A,et al.Rescue of glutamate transport in the lateral habenula alleviates depression- and anxiety-like behaviors in ethanol-withdrawn rats [J].Neuropharmacology,2018,129:47-56.
• [49] Gourley S L,Espitia J W,Sanacora G,et al.Antidepressant-like properties of oral riluzole and utility of incentive disengagement models of depression in mice [J].Psychopharmacology,2012,219(3):805-814.
• [50] Pittenger C,Coric V,Banasr M,et al.Riluzole in the treatment of mood and anxiety disorders [J].CNS Drugs,2008,22(9):761-786.
• [51] de Boer J N,Vingerhoets C,Hirdes M,et al.Efficacy and tolerability of riluzole in psychiatric disorders:A systematic review and preliminary meta-analysis [J].Psychiatry Research,2019,278:294-302.
• [52] Yao R,Wang H,Yuan M,et al.Efficacy and safety of riluzole for depressive disorder:A systematic review and meta-analysis of randomized placebo-controlled trials [J].Psychiatry Research,2020,284:112750.